Michael Shipton - Science 37 Chief Officer
| SNCEDelisted Stock | USD 0.28 0.02 7.69% |
Insider
Michael Shipton is Chief Officer of Science 37 Holdings
| Age | 52 |
| Phone | 984 377 3737 |
| Web | https://www.science37.com |
Michael Shipton Latest Insider Activity
Tracking and analyzing the buying and selling activities of Michael Shipton against Science 37 stock is an integral part of due diligence when investing in Science 37. Michael Shipton insider activity provides valuable insight into whether Science 37 is net buyers or sellers over its current business cycle. Note, Science 37 insiders must abide by specific rules, including filing SEC forms every time they buy or sell Science 37'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Michael Shipton over six months ago Disposition of 3006 shares by Michael Shipton of Science 37 at 5.73 subject to Rule 16b-3 | ||
Michael Shipton over a year ago Exercise or conversion by Michael Shipton of 100000 shares of Science 37 subject to Rule 16b-3 | ||
Michael Shipton over a year ago Acquisition by Michael Shipton of 522793 shares of Science 37 subject to Rule 16b-3 |
Science 37 Management Efficiency
The company has return on total asset (ROA) of (0.2831) % which means that it has lost $0.2831 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1852) %, meaning that it created substantial loss on money invested by shareholders. Science 37's management efficiency ratios could be used to measure how well Science 37 manages its routine affairs as well as how well it operates its assets and liabilities.Science 37 Holdings currently holds 1.32 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Science 37 Holdings has a current ratio of 6.19, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Science 37's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Jon Hunt | Heartbeam | 68 | |
| Steven Sabes | FOXO Technologies | 56 | |
| Daniel Barton | Forian Inc | 59 | |
| Branislav Vajdic | Heartbeam | 69 | |
| Lakshmanan Kannappan | Healthcare Triangle | 57 | |
| Jona Raasch | National Research Corp | 65 | |
| Max Wygod | Forian Inc | 36 | |
| Lawrence FACS | Nutex Health | 75 | |
| Suresh Venkatachari | Healthcare Triangle | 57 | |
| Mark Grove | Forian Inc | N/A | |
| Robert Potashnick | FOXO Technologies | N/A | |
| Steven Sobak | EUDA Health Holdings | 78 | |
| Jim Grauel | FOXO Technologies | N/A | |
| Tyler Danielson | FOXO Technologies | N/A | |
| BSN JD | Nutex Health | N/A | |
| Denise Pufal | Nutex Health | N/A | |
| Adam Dublin | Forian Inc | 58 | |
| FACC MD | Heartbeam | 65 | |
| David Terrell | Forian Inc | N/A | |
| Shibu Kizhakevilayil | Healthcare Triangle | 52 | |
| Andrew Douglas | Forian Inc | N/A | |
Management Performance
| Return On Equity | -1.19 | |||
| Return On Asset | -0.28 |
Science 37 Holdings Leadership Team
Elected by the shareholders, the Science 37's board of directors comprises two types of representatives: Science 37 inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Science. The board's role is to monitor Science 37's management team and ensure that shareholders' interests are well served. Science 37's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Science 37's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Troy Bryenton, Chief Officer | ||
| Christine JD, Chief Secretary | ||
| David Coman, CEO Director | ||
| Mike Zaranek, Chief Officer | ||
| Elisa Cascade, Chief Officer | ||
| Christopher Ceppi, Chief Officer | ||
| Margie Kooman, Vice Communications | ||
| Michael Shipton, Chief Officer | ||
| Irena Lambridis, VP Compliance | ||
| Drew Bustos, Chief Officer | ||
| James Young, Chief Officer | ||
| Darcy Forman, Chief Officer | ||
| Tyler Horn, VP Staff | ||
| Jonathan MD, Chief Officer |
Science Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Science 37 a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.19 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (2.07) % | |||
| Operating Margin | (0.60) % | |||
| Current Valuation | (21.22 M) | |||
| Shares Outstanding | 6.03 M | |||
| Shares Owned By Insiders | 16.89 % | |||
| Shares Owned By Institutions | 52.18 % | |||
| Number Of Shares Shorted | 13.83 K | |||
| Price To Book | 0.67 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Science Stock
If you are still planning to invest in Science 37 Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Science 37's history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |